For flibanserin to be marketed Pharmacy Journal, it must still be approved by the Food and Drug Administration, but it usually follows the experts’ recommendations. A final decision is due August 18.
29/05/2010
Martyn Sibley is a disability inclusion changemaker, entrepreneur, advisor, and author exploring how societies thrive when everyone is included. His work spans business, media, technology, and policy, with a focus on how inclusive thinking and design can create better outcomes not only for disabled people, but for society as a whole.